We have a portfolio of novel therapeutic candidates

We examine the genetic variations and how they affect specific diseases in specific patients and focus on bringing innovative tailored therapies to patients.


We have a portfolio of novel therapeutic candidates, focused primarily on renal disease and cardiovascular disease.

Our goal is to utilize our study of genetic variations to ultimately deliver precise treatments to specific patients who presently have an unmet medical need in these diseases. We believe that no two patients are identical in their treatment needs and there are vast number of patients around the world whose needs are presently unmet. Using our precise approach to study the genetic variations of diseases and the patients they affect, we understand how a personalized drug in these complex diseases may behave before we ever begin a clinical trial.

New Entrants
PreclinicalPhase 1Phase 2Phase 3